Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ena-DATASET-DUKE-NUS-31-07-2017-04:47:07:192-1093 - samples

ABSTRACT: This dataset contains 77 tumor-normal pairs of exome sequencing data of HCC patient from National Taiwan University, Taiwan.

PROVIDER: EGAD00001003467 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

ena-DATASET-DUKE-NUS-28-07-2017-05:02:39:359-1035 - samples

Project description:This dataset contains 21 tumor-normal pairs of exome sequencing data of HCC patient from Chang Gung Memorial Hospital, Taiwan.

| EGAD00001003466 | EGA

From Trial to Implementation, Bringing Team-Based Learning Online-Duke-NUS Medical School's Response to the COVID-19 Pandemic.

Project description: Not available

| S-EPMC7402390 | biostudies-literature

Gene expression profile of hepatocellular carcinomain in Taiwan (subset 2)

Project description:In this study, we used RNA-seqeuncing to develop gene expression profile of HCC patients in Taiwan.

2022-03-01 | GSE141200 | GEO

Gene expression profile of hepatocellular carcinomain in Taiwan (subset 1)

Project description:In this study, we used RNA-seqeuncing to develop gene expression profile of HCC patients in Taiwan.

2022-03-01 | GSE141198 | GEO

Mycobacterium tuberculosis OFXR-31

Project description:TB-ARC - Taiwan

| PRJNA221518 | ENA

DUKE-NUS

Project description:Organisation EGAO00000000230

| EGAO00000000230 | EGA

Helicobacter pylori strain:Taiwan-47

Project description:Helicobacter pylori Genome sequencing of Taiwan-47

| PRJNA259568 | ENA

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer (II)

Project description:This microarray dataset contains 51 triple-negative breast cancers, 25 normal breast tissues, and 106 luminal breast cancers (reanalyzed data from Series GSE24124, GSE9309, and GSE17040). Keywords: Expression profiling by array Specimens of breast cancer tissue were collected and snap-frozen from breast cancer patients who had surgery between 1995 and 2008 at National Taiwan University Hospital (NTUH, Taipei, Taiwan). Clinicopathological information was obtained for all breast cancer patients along with informed consent. The AJCC/UICC TNM system was used for breast cancer staging classification.

2014-01-02 | E-GEOD-53752 | biostudies-arrayexpress

Intracellular accumulation of IFN-λ4 contributes to protection from liver cirrhosis by inducing ER stress and enhancing IRF1 signaling

Project description:Chronic hepatitis C virus (HCV) infection and cirrhosis are major risk factors for developing hepatocellular carcinoma (HCC). Genetic polymorphisms in the IFNL3/IFNL4 locus have been associated both with poor clearance of HCV and protection from liver fibrosis, an early stage of cirrhosis. Here, we aimed to address the genetic and functional relationships between IFNL3/IFNL4 polymorphisms, cirrhosis, and HCC risk. We evaluated associations between IFNL4 genotype (presence of rs368234815-dG or rs12979860-T alleles) with cirrhosis and HCC risk in patients with chronic HCV - 2,931 from Taiwan and 3,566 from Japan, and with gene expression and somatic mutations in 370 HCC tumors in The Cancer Genome Atlas (TCGA). Functional analyses were performed in primary human hepatocytes and hepatic stellate cells and a panel of hepatoma HepG2 cell lines with gene-edited IFNLR1 and inducible expression of IFN-λ3 or IFN-λ4. We detected associations between IFNL4 genotype and decreased risk of cirrhosis (OR=0.66, 95%CI=0.46-0.93, P=0.018, in Taiwan), but increased risk of HCC in patients without HCV clearance (OR=1.28, 95%CI=1.07-1.52, P=0.0058, in Japan). IFNL4 genotype was also associated with reduced cell proliferation and enrichment of CTNNB1 mutations in HCC tumors in TCGA. Reduced proliferation in hepatic cells was contributed by intracellular accumulation of IFN-λ4 leading to induction of ER stress and enhanced IRF1 signaling. The strong anti-proliferative effects of IFN-λ4 in hepatic cells could explain the association of IFNL3/IFNL4 polymorphisms with decreased cirrhosis. However, by sustaining persistent HCV infection, IFN-λ4 may contribute to the development of CTNNB1 mutations and increased risk of HCC in patients without viral clearance.

2021-09-15 | GSE145038 | GEO

ena-DATASET-DUKE-NUS-28-02-2017-10:02:11:279-288 - samples

Project description:This dataset contains whole exome sequence of six HCC patients from Qidong China who are very likely exposed to aflatoxin.

| EGAD00001003194 | EGA